Back
Corcept Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
36
CORT
Corcept Therapeutics, Inc.
Last Price:
$34.18
Seasonality Move:
8.39%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and CORT is experiencing slight selling pressure.
Corcept Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 39.39 | Sell |
| 20-day SMA: | 41.17 | Sell |
| 50-day SMA: | 54.09 | Sell |
| 200-day SMA: | 69.18 | Sell |
| 8-day EMA: | 37.76 | Sell |
| 20-day EMA: | 30.67 | Buy |
| 50-day EMA: | 17.96 | Buy |
| 200-day EMA: | 5.57 | Buy |
Corcept Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.79 | Buy |
| Relative Strength Index (14 RSI): | 31.57 | Sell |
| Chaikin Money Flow: | -465831 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.73 - 43.43) | Sell |
| Bollinger Bands (100): | (46.61 - 85.75) | Sell |
Corcept Therapeutics, Inc. Technical Analysis
| Feb 5 | Feb 6 | Feb 9 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 17 | Feb 18 | Feb 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corcept Therapeutics, Inc. Stock
Is Corcept Therapeutics, Inc. Stock a Buy?
-
Corcept Therapeutics, Inc. share price is 34.24 while CORT 8-day simple moving average is 39.39, which is a Sell signal.
-
The stock price of CORT is 34.24 while Corcept Therapeutics, Inc. 20-day SMA is 41.17, which makes it a Sell.
-
Corcept Therapeutics, Inc. 50-day simple moving average is 54.09 while CORT share price is 34.24, making it a Sell technically.
-
CORT stock price is 34.24 and Corcept Therapeutics, Inc. 200-day simple moving average is 69.18, creating a Sell signal.
CORT Technical Analysis vs Fundamental Analysis
Sell
36
Corcept Therapeutics, Inc. (CORT)
is a Sell
Is Corcept Therapeutics, Inc. a Buy or a Sell?
-
Corcept Therapeutics, Inc. stock is rated a SellThe current Corcept Therapeutics, Inc. [CORT] share price is $34.24. The Score for CORT is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
Corcept Therapeutics, Inc. Stock Info
Market Cap:
3.6B
Price in USD:
34.24
Share Volume:
11.8M
Corcept Therapeutics, Inc. 52-Week Range
52-Week High:
117.33
52-Week Low:
28.66
Sell
36
Corcept Therapeutics, Inc. (CORT)
is a Sell
Corcept Therapeutics, Inc. Share Price Forecast
-
What is the Corcept Therapeutics, Inc. stock price today?The Corcept Therapeutics, Inc. stock price is 34.24 USD today.
-
Will CORT stock go up or go down?Corcept Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Corcept Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corcept Therapeutics, Inc. is overvalued.
Is Corcept Therapeutics, Inc. Stock a Buy?
-
Corcept Therapeutics, Inc. share price is 34.24 while CORT 8-day exponential moving average is 37.76, which is a Sell signal.
-
The stock price of CORT is 34.24 while Corcept Therapeutics, Inc. 20-day EMA is 30.67, which makes it a Buy.
-
Corcept Therapeutics, Inc. 50-day exponential moving average is 17.96 while CORT share price is 34.24, making it a Buy technically.
-
CORT stock price is 34.24 and Corcept Therapeutics, Inc. 200-day simple moving average is 5.57, creating a Buy signal.
Fundamental Analysis of Corcept Therapeutics, Inc.
Is Corcept Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.46 per share, and an increase next year of $2.75 per share.
Technical Analysis of Corcept Therapeutics, Inc.
Should I short Corcept Therapeutics, Inc. stock?
-
CORT Moving Average Covergence Divergence (MACD) indicator is 8.79, suggesting Corcept Therapeutics, Inc. is a Buy
-
Corcept Therapeutics, Inc. Relative Strength Index (RSI) is 31.57, which suggest Corcept Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Corcept Therapeutics, Inc. is (36.73 - 43.43), which suggest Corcept Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Corcept Therapeutics, Inc. is (46.61 - 85.75), which suggest Corcept Therapeutics, Inc. is a Sell
* Corcept Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.